ArticleEClinicalMedicine2024

Transcatheter arterial chemoembolisation combined with lenvatinib plus camrelizumab as conversion therapy for unresectable hepatocellular carcinoma: a single-arm, multicentre, prospective study.

Xu-Kun Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.